INTRODUCTION AND OBJECTIVES: Near-infrared fluorescence (NIRF) technology in robotic surgery allows visualization of tissue fluorescence after giving intravenous indocyanine green (ICG). While this technology has been available for five years and has been adopted for perfusion assessment, it has not been widely adopted for achieving differential fluorescence (DF) of normal kidney versus tumors during robotic partial nephrectomy (RPN). Normal kidney fluoresces with NIRF due to bilitranslocase transport of ICG into proximal tubule cells while most renal tumors, including most renal cell carcinomas (RCC), should not fluoresce. This differential fluorescence of normal kidney and RCC allows better visualization of tumor edges and visual assessment of margins during and after tumor resection with fluorescence confirming a grossly negative margin. Most surgeons have abandoned using NIRF for DF citing inability to reliably achieve fluorescence of the kidney and not the tumor. While the dose of ICG is not critical when used to assess perfusion, improper ICG dosing will cause the tumor to fluoresce and make it indistinguishable from normal kidney. We developed an ICG dosing regimen providing reliable DF in most cases and report our success with NIRF.
INTRODUCTION AND OBJECTIVES: Near-infrared fluorescence (NIRF) technology in robotic surgery allows visualization of tissue fluorescence after giving intravenous indocyanine green (ICG) . While this technology has been available for five years and has been adopted for perfusion assessment, it has not been widely adopted for achieving differential fluorescence (DF) of normal kidney versus tumors during robotic partial nephrectomy (RPN) . Normal kidney fluoresces with NIRF due to bilitranslocase transport of ICG into proximal tubule cells while most renal tumors, including most renal cell carcinomas (RCC), should not fluoresce. This differential fluorescence of normal kidney and RCC allows better visualization of tumor edges and visual assessment of margins during and after tumor resection with fluorescence confirming a grossly negative margin. Most surgeons have abandoned using NIRF for DF citing inability to reliably achieve fluorescence of the kidney and not the tumor. While the dose of ICG is not critical when used to assess perfusion, improper ICG dosing will cause the tumor to fluoresce and make it indistinguishable from normal kidney. We developed an ICG dosing regimen providing reliable DF in most cases and report our success with NIRF.
METHODS: RPN was performed with NIRF imaging in 253 tumors, the largest reported experience to date. Intraoperative assessment of tumor fluorescence was prospectively recorded at the time of surgery by the surgeon before pathologic assessment of tumors. The ICG dosing regimen included test doses beginning as low as 0.25cc to avoid overdosing and panfluorescence.
RESULTS: Mean age was 58yrs (26-89) with mean body mass index of 32kg/m2 (18-63). Mean tumor size on imaging was 3.4cm (0.7-9.7) with mean R.E.N.A.L. nephrometry score of 7.3 (4-11), including 32 hilar tumors and 164 tumors >50% endophytic. Mean operative time was 170min. Among all 253 tumors, DF was successfully achieved in 217 (86%). Among 36 tumors that undesirably fluoresced, 8 were oncocytomas and 4 were chromophobe RCC, which are both known to express bilitranslocase, with 4 angiomyolipomas. Among 25 oncocytomas, 8 fluoresced such that DF was only successful in 68% of oncocytomas. Among 209 RCCs, 186 did not fluoresce (89%). Only 1 positive margin occurred (0.4%).
CONCLUSIONS: Robotic NIRF imaging was highly reliable (89%) in visualizing DF of RCC versus normal parenchyma but less so in oncocytomas as expected. Further study is needed to determine whether this contributed to the <1% positive margin rate.
Source of Funding: none
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INTRODUCTION AND OBJECTIVES:
The key advantages of LESS are better cosmesis and less morbidity. Meanwhile, instrument clashing and loss of triangulation are the main limitations. ML overcomes such limitations but with multiple mini-incisions. The two approaches were compared.
METHODS: A prospective randomized trial was conducted to compare the LESS versus ML nephrectomy. LESS nephrectomy was performed via a skin incision at the umbilicus. Three ports (5mm each) were placed through this incision. Meanwhile, ML nephrectomy was done through 3 ports (3-5 mm each) where the camera port was placed at the umbilicus. The cosmetic outcome (primary end point), operative time, blood loss, hospital stay and complications were recorded and compared. Patient scar assessment questionnaire (PSAQ) was used for evaluation of cosmetic outcome and patient satisfaction with the scars at 3 month postoperatively. The PSAQ consists of 5 sub-scales: appearance, symptoms, consciousness, satisfaction with appearance and satisfaction with symptoms. Each sub-scales consists of a set of items with 4 point categorical responses, scoring 1-4 points with 1 point assigned to the most favorable category and 4 assigned to the least favorable. Experienced laparoscopic surgeons performed all procedures. The estimate sample size was 62 patients. The cases were randomized using a computer generated numbers.
RESULTS: Thirty-one patients were included in each arm. Preoperative data were comparable in both groups. The cosmetic outcome had no statistical difference in the two groups (Table:1 ). The operative time was significantly longer in LESS group (119 AE 23 versus 73 AE 14 min, p <0.001). The estimated blood loss was less in ML patients (55 AE 18 versus 102 AE 27 ml in LESS group, p <0.001). Extra port was needed in 3 and 4 patients in LESS and ML groups respectively (p>0.05). Conversion to conventional laparoscopy was recorded in one of LESS cases. Conversion to open surgery was reported in one patient in each group (p>0.05). The complication rates and grades were comparable in both groups. Hospital stay was 2.1 and 1.8 days for LESS and ML groups (p>0.05).
CONCLUSIONS: ML represents a real alternative to LESS with comparable cosmetic outcome, shorter operative time and less blood loss.
Source of Funding: none
MP52-07 DOES THE USE OF 5 MM INSTRUMENTS AFFECT THE OUTCOMES OF ROBOT-ASSISTED LAPAROSCOPIC PYELOPLASTY IN SMALLER WORKING SPACES? A COMPARATIVE ANALYSIS OF INFANTS AND OLDER CHILDREN
Minki Baek*, Seoul, Korea, Republic of; M. Selcuk Silay, Istanbul, Turkey; Jason Au, Gene Huang, Abhishek Seth, Nicolette Janzen, David Roth, Chester Koh, Houston, TX INTRODUCTION AND OBJECTIVES: Pediatric robot-assisted laparoscopic (RAL) pyeloplasty has become a viable minimally invasive surgical option for ureteropelvic junction obstruction (UPJO) with several previous reports on its efficacy and safety. However, RAL pyeloplasty in infants can be a challenging procedure due to the smaller working spaces, and the use of the larger 8 mm instruments for these Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e705 patients instead of the 5 mm instruments is common due to the shorter wrist lengths. We hypothesized that the use of 5 mm instruments for RAL pyeloplasty in infants with smaller working spaces will not affect the perioperative parameters and surgical outcomes in comparison to older children with larger working spaces. METHODS: We compared the perioperative parameters and surgical outcomes of RAL pyeloplasties performed by a single surgeon in infants and non-infant pediatric patients over a 2 year period using an 8.5 mm camera and 5 mm robotic instruments. Patient demographics, operative times, intra-and post-operative complications, hospital pain medication usage, hospital length of stay, and treatment success rates were compared between the two groups.
RESULTS: A total of 65 pediatric RAL pyeloplasties were included in the study (16 infants and 49 non-infant pyeloplasties). There were no significant differences in gender, laterality, proportion of re-do pyeloplasty, or preoperative hydronephrosis grade between the two groups. All procedures were performed without conversion to open surgery or significant perioperative complications. There were no differences in segmental operative times (total operative time, console time, port placement time, time for dissection to UPJO, and anastomosis time), hospital pain medication usage, and hospital length of stay between the two groups (p > 0.05 for all comparisons). The treatment success rates were 93.8% (15/16) and 100% (49/49), respectively (p ¼ 0.08).
CONCLUSIONS: RAL pyeloplasty is a safe and effective surgical modality even in infants with comparable perioperative parameters and outcomes as those in older children. The use of 5 mm instruments in infants with smaller working spaces does not affect these parameters as well, while offering the potential for improved cosmesis. 
